NCT01160900
Unknown
3 期
Phase III Study, Multivessel Percutaneous Treatment During Myocardial Infarction
概览
- 阶段
- 3 期
- 干预措施
- 未指定
- 疾病 / 适应症
- Myocardial Infarction
- 发起方
- Azienda Ospedaliera San Camillo Forlanini
- 入组人数
- 180
- 试验地点
- 1
- 主要终点
- death at 30 days
- 最后更新
- 15年前
概览
简要总结
Few reports described outcomes of complete compared with infarct related artery (IRA) only revascularization in patients with ST elevation myocardial infarction (STEMI) and multivessel coronary disease (CAD).
The purpose of this study is to determine outcome (death, myocardial infarction, target vessel failure) of 180 consecutive patients with STEMI and multivessel CAD undergoing primary angioplasty.
Before the first angioplasty patients are randomized to 2 different strategies: 1) culprit vessel angioplasty only, 2) staged revascularization.
研究者
入排标准
入选标准
- •myocardial acute infarction
- •prolonged chest pain (\>20 minute) started less \<12 hours before arrive in hospital
- •ST segment elevation of \>1mm in \>2 contiguous leads
- •new left bundle branch block
- •diameter of the coronary suitable of angioplasty \>2mm
- •the patients agrees to the study protocol and provides a written consensus
- •two or more coronary suitable for angioplasty
排除标准
- •refused written consensus
- •hypersensitivity or contraindication to any of the following medications: heparin bivalirudin aspirin prasugrel stainless steel
- •history of bleeding
- •cardiogenic shock (PA \< 90mmHg)
- •chronic total occlusion in the second lesion
- •TIMI Flow \< II in the culprit lesion
- •recent pregnancy
- •history of intra-cerebral major hemorrhagic stroke
- •an elective surgical procedure is planned that would necessitate interruption of thienopyridines during the first six months post enrollment life expectancy \<1 year
结局指标
主要结局
death at 30 days
时间窗: 1 month
stent thrombosis
时间窗: 1 year
target vessel failure
时间窗: 1 year
re-acute myocardial infarction
时间窗: 1 month
次要结局
- bleeding(1 month)
- timi frame count(1 day)
- vascular site access complications(1 month)
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMINon-ST-elevation Myocardial InfarctionMultivessel Coronary Artery DiseaseNCT05786131Leipzig Heart Science gGmbH3,390
已完成
4 期
YUKON Choice Versus TAXUS Liberté in Diabetes MellitusCoronary ArteriosclerosisNCT00368953University of Leipzig240
已完成
不适用
Complete Infarct Related Artery Revascularization in Acute Myocardial InfarctionMyocardial InfarctionNCT01642784Fundacja Ośrodek Badań Medycznych100
暂停
不适用
Multicenter trial of elective revascularization in patients with diabetes mellitus and mild anginal complaints.NL-OMON20816* The Netherlands Heart Foundation (NHS)* The Netherlands Organisation for Health Research and Development (ZonMw)800
已完成
不适用
Acute Revascularization Treatment in Ischemic Stroke Patients With COVID-19Ischemic StrokeCovid19NCT04895462Centre Hospitalier Universitaire Vaudois15,128